Observational studyJournal of diabetes investigation2021

Dipeptidyl peptidase-4 inhibitor might exacerbate Graves' disease: A multicenter observational case-control study.

Tomonori Sekizaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.